Enhancing prime editing by Csy4-mediated processing of pegRNA

Yao Liu,Guang Yang,Shuhong Huang,Xiangyang Li,Xin Wang,Guanglei Li,Tian Chi,Yulin Chen,Xingxu Huang,Xiaolong Wang
DOI: https://doi.org/10.1038/s41422-021-00520-x
IF: 44.1
2021-06-08
Cell Research
Abstract:<p>Cell Research, Published online: 08 June 2021; <a href="https://www.nature.com/articles/s41422-021-00520-x">doi:10.1038/s41422-021-00520-x</a></p>Enhancing prime editing by Csy4-mediated processing of pegRNA
cell biology
What problem does this paper attempt to address?
The main problem this paper attempts to address is improving the efficiency of "prime editing" in gene editing technology. Specifically, the authors found that certain structural features of pegRNA (prime editing guide RNA) in the traditional prime editing system (PE3) might lead to its self-circularization, thereby affecting editing efficiency. To overcome this issue, the authors proposed a series of improvements, including: 1. **Preventing pegRNA circularization**: By deleting or replacing specific sequences in pegRNA (such as PBS), or adding a Csy4 recognition site at the 3' end of pegRNA to form a hairpin structure, to prevent circularization. 2. **Optimizing pegRNA expression**: By modifying specific bases in the pegRNA scaffold (replacing the fourth uracil in a series of consecutive uracils with cytosine), eliminating potential transcription termination signals, thereby increasing the expression level of pegRNA. 3. **Co-expressing pegRNA and nick-sgRNA**: By fusing pegRNA and nick-sgRNA into one transcript and using Csy4 enzyme to cleave and release these two RNAs, optimizing their ratio, further improving editing efficiency. These improvements collectively constitute the enhanced prime editing system (ePE), significantly increasing the efficiency of precise gene editing in different cell lines, especially in terms of point mutations, insertions, and deletions. At the same time, the study also verified that the fidelity of the ePE system is comparable to that of the traditional PE system, ensuring its safety in therapeutic and clinical applications.